Back to today’s briefing

Story perspectives

DSM-Firmenich Sells Animal Nutrition Unit for €2.2 Billion

2/10/2026

28 7 Full Breakdown

Summary

Story summary

dsm-firmenich has agreed to sell its Animal Nutrition & Health (ANH) business to CVC Capital Partners for €2.2 billion, with an earnout up to €500 million.
dsm-firmenich will retain a 20% equity stake in the new ANH entities.
The deal is expected to close by the end of 2026, subject to regulatory approvals.
The divestment follows the €1.5 billion sale of its feed enzymes business.

History

Historical Context

In 2006, Roche sold its animal nutrition division for €1.5 billion to CVC Capital Partners, reflecting a broader trend of consolidation in the pharmaceutical industry. This shift mirrors dsm-firmenich's recent €2.2 billion divestment of its Animal Nutrition & Health business, emphasizing a strategic focus on core competencies that fosters specialization and innovation within the sector.

1 of 2

Story summary

dsm-firmenich has agreed to sell its Animal Nutrition & Health (ANH) business to CVC Capital Partners for €2.2 billion, with an earnout up to €500 million.
dsm-firmenich will retain a 20% equity stake in the new ANH entities.
The deal is expected to close by the end of 2026, subject to regulatory approvals.
The divestment follows the €1.5 billion sale of its feed enzymes business.

1 / 2